Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InKemia IUCT Group operates as a knowledge-based biotech holding focused on generating high-value technology for the chemical, pharmaceutical, biotechnology, cosmetic, nutraceutical and related industries. The group commercializes this know-how through R&D co-development projects with industry partners, contract research services, licensing of patents/technologies to third parties, technical consultancy/training programs and creation of spin-out companies. Its core competencies include custom chemical synthesis (hit-finding to lead optimization), analytical method development/validation for pharmaceuticals including impurity profiling/isolation/purification studies. The group also provides manufacturing/control services for pharmaceutical products including active pharmaceutical ingredients production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InKemia IUCT Group.